Nov 4, 2026 09:01AM
Nov 4, 2026 09:00AM
Oct 29, 2026 07:00AM
Sep 11, 2026 07:24AM
Jul 28, 2026 01:38PM
Jul 28, 2026 07:00AM
Jul 13, 2026 04:00AM Incyte reports 81% bleed reduction in VWD drug trial data
Jul 13, 2026 04:00AM
Jul 6, 2026 08:39AM
Jul 6, 2026 08:39AM
Jun 26, 2026 09:00AM
Jun 26, 2026 09:00AM
Jun 10, 2026 07:11AM
Jun 9, 2026 09:11AM Stifel Reiterates Buy Rating on Incyte (INCY)
Jun 8, 2026 02:49PM
Jun 8, 2026 07:00AM
Jun 8, 2026 07:00AM
Jun 2, 2026 04:37AM
May 6, 2026 04:30PM
Apr 28, 2026 07:00AM
Feb 10, 2026 07:00AM Incyte Reports Fourth Quarter and Full Year 2025 Financial Results
Dec 3, 2025 04:30PM
Nov 4, 2025 07:01AM
Nov 4, 2025 07:01AM
Oct 28, 2025 07:00AM
Sep 24, 2025 04:30PM
Sep 18, 2025 04:15AM
Aug 27, 2025 04:15PM Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Aug 25, 2025 08:00AM
Aug 25, 2025 08:00AM
Jul 29, 2025 07:00AM
Jul 2, 2025 04:30PM
Jun 26, 2025 12:27PM
Jun 26, 2025 10:36AM
Jun 26, 2025 09:18AM Incyte (INCY) CEO change timing 'feels right' - Stifel
Jun 26, 2025 07:30AM
Jun 26, 2025 07:30AM
Apr 29, 2025 07:00AM
Feb 10, 2025 07:00AM
Oct 30, 2024 05:47AM
Oct 29, 2024 07:00AM
Aug 19, 2024 05:58AM JMP Securities Reiterates Market Perform Rating on Incyte (INCY)
Jul 30, 2024 07:03AM
Jul 30, 2024 07:00AM
Jul 2, 2024 04:15AM
May 30, 2024 04:05PM
May 21, 2024 01:16PM
May 21, 2024 01:15PM
May 1, 2024 06:30AM Incyte (INCY) PT Lowered to $60 at RBC Capital
Apr 30, 2024 03:17PM

1,206,874 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All